Print Page  Close Window

News Release

Emergent BioSolutions to Participate in the Goldman Sachs 39th Annual Global Healthcare Conference

GAITHERSBURG, Md., June 08, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that a member of the company’s senior management team will present a corporate overview and discuss recent business developments during a fireside chat at the Goldman Sachs 39th Annual Global Healthcare Conference on June 13, 2018 at 2:00pm Pacific Time in Rancho Palos Verdes, California.

The audio portion of the fireside chat will be accessible live from the Investors page on the Emergent website www.emergentbiosolutions.com. The replay will be available for six months following the presentation.

ABOUT EMERGENT BIOSOLUTIONS INC.
Emergent BioSolutions Inc. is a global life sciences company seeking to protect and enhance life by focusing on providing specialty products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. Through our work, we envision protecting and enhancing 50 million lives with our products by 2025. Additional information about the company may be found at www.emergentbiosolutions.com. Follow us on Twitter @emergentbiosolu and Instagram @life_at_emergent.

Investor Contact:
Robert G. Burrows
Vice President, Investor Relations
240-631-3280
BurrowsR@ebsi.com

Media Contact:
Lynn Kieffer
Vice President, Corporate Communications
240-631-3391
KiefferL@ebsi.com

Primary Logo

Emergent BioSolutions